Literature DB >> 22212428

A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma.

Bo-an Li1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22212428      PMCID： PMC4010270          DOI： 10.1038/aps.2011.198

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  14 in total

1.  The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis.

Authors:  E D Foehr; J Bohuslav; L F Chen; C DeNoronha; R Geleziunas; X Lin; A O'Mahony; W C Greene
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

Review 2.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.

Authors:  David P Bartel; Chang-Zheng Chen
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

3.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

Authors:  Y Murakami; T Yasuda; K Saigo; T Urashima; H Toyoda; T Okanoue; K Shimotohno
Journal:  Oncogene       Date:  2006-04-20       Impact factor: 9.867

4.  Viral delivery of recombinant short hairpin RNAs.

Authors:  Beverly L Davidson; Scott Q Harper
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

5.  MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

Authors:  S Zhang; C Shan; G Kong; Y Du; L Ye; X Zhang
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

8.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

Review 9.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

Review 10.  MicroRNA involvement in hepatocellular carcinoma.

Authors:  Laura Gramantieri; Francesca Fornari; Elisa Callegari; Silvia Sabbioni; Giovanni Lanza; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310
View more
  6 in total

1.  Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.

Authors:  Yun-Yong Park; Sang-Bae Kim; Hee Dong Han; Bo Hwa Sohn; Ji Hoon Kim; Jiyong Liang; Yiling Lu; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Gordon B Mills; Anil K Sood; Ju-Seog Lee
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

Review 2.  Friend or foe: the role of microRNA in chemotherapy resistance.

Authors:  Haoran Li; Burton B Yang
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

3.  Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.

Authors:  Lixia Fan; Linqi Chen; Xiaoling Ni; Shicheng Guo; Yinghui Zhou; Chenji Wang; Yabiao Zheng; Fangyuan Shen; Vijay Kumar Kolluri; Merlin Muktiali; Zhenhong Zhao; Junjie Wu; Dunmei Zhao; Zhenglei He; Xulong Feng; Ziyu Yuan; Juan Zhang; Li Jin; Jiucun Wang; Minghua Wang
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

4.  CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.

Authors:  Quan Liang; Qingjuan Yao; GuoYing Hu
Journal:  Open Med (Wars)       Date:  2019-12-04

5.  miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.

Authors:  Ovidiu-Leonard Braicu; Liviuta Budisan; Rares Buiga; Ancuta Jurj; Patriciu Achimas-Cadariu; Laura Ancuta Pop; Cornelia Braicu; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2017-08-28       Impact factor: 4.147

6.  Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the RASSF1A Gene.

Authors:  Yajing Huang; Cheng Zhou; Huihong Wen; Yongxu Chen; Yingjie Xie; Xiaohe Lan; Juze Lin; Xuhui Huang; Yousheng Mo; Cong Yang; Qi Wang; Changjun Wang
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.